Observational studyCancer immunology, immunotherapy : CII2018

Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer.

Lourdes Barrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.